kabutan

TOWA PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%, Oct-Dec Ordinary Profit Increases by 5%

Fri Feb 13, 2026 3:30 pm JST Earnings

4553 TOWA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

TOWA PHARMACEUTICAL CO.,LTD. <4553> [TSE Prime] announced its financial results after the market closed on February 13th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 10.3% from the same period last year, reaching 23.9 billion yen. Progress toward the full-year plan of 25.3 billion yen was 94.8%, also surpassing the five-year average of 81.2%.

Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to significant drop 70.2% from the same period last year to 1.31 billion yen.

In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 5.2% from the same period last year, reaching 12.0 billion yen. The operating profit margin rose from 11.5% in the same period last year to 12.3%.

Kabutan News

Actual Results

Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Dec, 2023 168,325 13,204 17,169 11,518 234.0 70.1 Feb 13, 2024 J-GAAP
Apr - Dec, 2024 193,737 18,611 21,756 14,624 297.1 83.2 Feb 13, 2025 J-GAAP
Apr - Dec, 2025 204,065 19,490 23,988 17,082 347.0 94.8 Feb 13, 2026 J-GAAP
YoY +5.3% +4.7% +10.3% +16.8% +16.8%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Oct - Mar, 2024 136,190 12,729 15,814 12,431 252.5 40 May 15, 2025 J-GAAP
Oct - Mar, 2025 Guidance 149,524 16,557 13,321 9,486 192.7 40 Nov 10, 2025 J-GAAP
YoY +9.8% +30.1% -15.8% -23.7% -23.7%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 227,934 17,647 24,477 16,173 328.6 60 May 14, 2024 J-GAAP
Mar, 2025 259,594 23,242 26,152 18,986 385.7 70 May 15, 2025 J-GAAP
Mar, 2026 Guidance 280,000 27,000 25,300 17,700 359.6 80 May 15, 2025 J-GAAP
YoY +7.9% +16.2% -3.3% -6.8% -6.8%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2024 70,333 8,098 11,418 8,069 163.9 11.5 Feb 13, 2025 J-GAAP
Jan - Mar, 2025 65,857 4,631 4,396 4,362 88.6 7.0 May 15, 2025 J-GAAP
Apr - Jun, 2025 65,149 5,206 3,953 2,513 51.1 8.0 Aug 7, 2025 J-GAAP
Jul - Sep, 2025 65,327 5,237 8,026 5,701 115.8 8.0 Nov 10, 2025 J-GAAP
Oct - Dec, 2025 73,589 9,047 12,009 8,868 180.2 12.3 Feb 13, 2026 J-GAAP
YoY +4.6% +11.7% +5.2% +9.9% +9.9%

Related Articles